Item 1A. Risk Factors
Item 1A. Risk Factors
 
There have been no material changes to the risk factors previously disclosed in the 2021 Form 10-K.
 
Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds
 
In connection with the Company’s acquisition of the remaining ownership interest of CloudCME as set forth above, the Company issued 208,567 shares of the Company’s common stock at the closing of such acquisition on May 18, 2022, which shares had a value of $4.1 million at the closing. These shares were issued to CloudCME's founder Karl Wilkens as partial payment of the purchase price to Mr. Wilkens in exchange for his ownership interest as noted above. These shares were issued in a private placement in reliance upon the exemption set forth in Section 4(a)(2) of the Securities Act.
 
On March 14, 2022, the Company announced an expansion of the share repurchase program authorized by the Company’s Board of Directors under which the Company may purchase up to an additional $10.0 million of its common stock. Pursuant to this authorization, repurchases may be made in the open market, including under a Rule 105b-1 plan, through privately negotiated transactions, or otherwise. Under this program, during the first six months of 2022 the Company repurchased 402,050 shares at an aggregate fair value of $8.1 million, reflecting an average price per share of $20.19 (excluding the cost of broker commissions). In addition, any future repurchases under the authorization will be subject to prevailing market conditions, liquidity and cash flow considerations, applicable securities laws requirements (including under Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as applicable), and other factors. The share repurchase program is scheduled to terminate on the earlier of March 13, 2023 or when the maximum dollar amount has been expended.
 
The table below sets forth activity under the stock repurchase plan for the three months ended June 30, 2022.
 
Period
 
(a) Total number of shares (or units) purchased
 
 
(b) Average price paid per share (or unit)(1)
 
 
(c) Total number of shares (or units) purchased as part of publicly announced plans or programs
 
 
(d) Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs
 
Month #1 (April 1 - April 30)
 
 
126,765
 
 
$
19.88
 
 
 
126,765
 
 
$
2,500,020
 
Month #2 (May 1 - May 31)
 
 
26,722
 
 
 
18.98
 
 
 
26,722
 
 
 
1,992,953
 
Month #3 (June 1 - June 30)
 
 
5,916
 
 
 
18.98
 
 
 
5,916
 
 
 
1,880,642
 
Total
 
 
159,403
 
 
$
19.70
 
 
 
159,403
 
 
$
1,880,642
 
 
 
(1)
The weighted average price paid per share of common stock does not include the cost of broker commissions.
 
20
Table of Contents
 
Item 6. Exhibits
 
 
(a)
Exhibits
 
10.1 (1)
HealthStream, Inc. 2022 Omnibus Incentive Plan
31.1
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2
Certification of the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.1 INS
Inline XBRL Instance Document – The instant document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.1 SCH
Inline XBRL Taxonomy Extension Schema
101.1 CAL
Inline XBRL Taxonomy Extension Calculation Linkbase
101.1 DEF
Inline XBRL Taxonomy Extension Definition Linkbase
101.1 LAB
Inline XBRL Taxonomy Extension Label Linkbase
101.1 PRE
Inline XBRL Taxonomy Extension Presentation Linkbase
104
The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, has been formatted in Inline XBRL
Management contract of compensatory plan or arrangement
(1)
Incorporated by reference from exhibit 10.1 filed on our Current Report on Form 8-K dated May 31, 2022.
 
21
Table of Contents
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
HEALTHSTREAM, INC.
 
 
 
 
July 28, 2022
By:
 
/s/ Scott A. Roberts
 
 
 
Scott A. Roberts
 
 
 
Chief Financial Officer
 
 
 
 
22
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.